Thailand, Philippines sign for AstraZeneca COVID-19 vaccine
Thailand on Friday signed a $200 million deal to procure 26 million doses of a trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021.
Thailand on Friday signed a $200 million deal to procure 26 million doses of a trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021.
Americans should be warned of coronavirus vaccine side effects, medical experts say
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects — such as body aches and bad headaches — so they will return for the second dose.
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects — such as body aches and bad headaches — so they will return for the second dose.
A vaccine won't end the COVID-19 crisis right away, experts say
Many challenges lie ahead — not just the logistical hurdles involved in the biggest vaccination campaign in U.S. history, but public fear and misinformation that could hinder the effort and kick the end of the pandemic further down the road.
Many challenges lie ahead — not just the logistical hurdles involved in the biggest vaccination campaign in U.S. history, but public fear and misinformation that could hinder the effort and kick the end of the pandemic further down the road.
AstraZeneca says COVID-19 vaccine 'highly effective' prevention
AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.
Sandy Springs retirement community will offer free COVID-19 vaccines to resident
A COVID-19 vaccine may be weeks away, but one local retirement community has already made plans to make sure its residents have access to it.
A COVID-19 vaccine may be weeks away, but one local retirement community has already made plans to make sure its residents have access to it.
WHO: ‘No evidence’ remdesivir an effective treatment for hospitalized COVID-19 patients
In a press release, the WHO said there is currently “no evidence that remdesivir improves survival and other outcomes in these patients.”
In a press release, the WHO said there is currently “no evidence that remdesivir improves survival and other outcomes in these patients.”
FDA to livestream public meeting on Pfizer-BioNTech potential COVID-19 vaccine
The U.S. Food and Drug Administration has set a public meeting on Dec. 10 to discuss approving Pfizer and BioNTech’s experimental COVID-19 vaccine and will livestream it on YouTube, Facebook and Twitter.
The U.S. Food and Drug Administration has set a public meeting on Dec. 10 to discuss approving Pfizer and BioNTech’s experimental COVID-19 vaccine and will livestream it on YouTube, Facebook and Twitter.
Pfizer, BioNTech apply for emergency use authorization of COVID-19 vaccine
Pfizer and its German partner BioNTech formally submitted their request Nov. 20 for FDA emergency use authorization.
Pfizer and its German partner BioNTech formally submitted their request Nov. 20 for FDA emergency use authorization.
What does emergency use for a coronavirus vaccine mean?
The first COVID-19 vaccines to be given in the U.S. are expected to get a green light from regulators under a process known as emergency use authorization.
The first COVID-19 vaccines to be given in the U.S. are expected to get a green light from regulators under a process known as emergency use authorization.
COVID-19 ‘immune memory’ could last at least 6 months, study suggests
According to the study, immunity to the coronavirus infection may last for at least six months, and potentially much longer, after a person was initially infected.
According to the study, immunity to the coronavirus infection may last for at least six months, and potentially much longer, after a person was initially infected.
Will COVID-19 vaccine protect kids? Pfizer launches new trial to find out
More than a million US children have contracted COVID-19, according to a new report. Yet, most of the testing for coronavirus vaccines have left children out. That is changing.
More than a million US children have contracted COVID-19, according to a new report. Yet, most of the testing for coronavirus vaccines have left children out. That is changing.
Pfizer to seek clearance soon; new data shows its COVID-19 vaccine is 95% effective
Pfizer announced more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective.
Pfizer announced more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective.
FDA allows 1st rapid virus test that gives results at home
U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home.
U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home.
Who will be the first to get coronavirus vaccines?
Health care workers are likely to receive the first coronavirus vaccines when supplies are limited, but a decision on who gets the first shots has not been made.
Health care workers are likely to receive the first coronavirus vaccines when supplies are limited, but a decision on who gets the first shots has not been made.
Moderna says its COVID-19 vaccine is nearly 95% effective
As the pandemic heats up across the US, COVID-19 vaccine researchers and volunteers woke up to good news: a leading vaccine candidate proved more effective than anyone had anticipated.
As the pandemic heats up across the US, COVID-19 vaccine researchers and volunteers woke up to good news: a leading vaccine candidate proved more effective than anyone had anticipated.
Russian, North Korean hackers target vaccine work, Microsoft says
Microsoft said that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were.
Microsoft said that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were.
COVID-19 vaccine: States sketch out plans, logistics for coming immunization effort
With a COVID-19 vaccine drawing closer, public health officials across the country are gearing up for the biggest vaccination effort in U.S. history
With a COVID-19 vaccine drawing closer, public health officials across the country are gearing up for the biggest vaccination effort in U.S. history
Feds, drug stores to distribute COVID-19 vaccines for free once available
When a COVID-19 vaccine is ready for distribution across the country, it will be offered for free through pharmacies.
When a COVID-19 vaccine is ready for distribution across the country, it will be offered for free through pharmacies.
Plant-based COVID-19 vaccine candidate enters Phase 2 trial
A biopharmaceutical company has announced positive Phase 1 trial results of a potential plant-based COVID-19 vaccine.
A biopharmaceutical company has announced positive Phase 1 trial results of a potential plant-based COVID-19 vaccine.
Pfizer says early data shows its COVID-19 test vaccine is more than 90% effective
The pharmaceutical company Pfizer announced Monday early data shows its candidate vaccine is more than 90% effective in preventing infection in volunteers who had not previously been exposed to the virus.
The pharmaceutical company Pfizer announced Monday early data shows its candidate vaccine is more than 90% effective in preventing infection in volunteers who had not previously been exposed to the virus.